Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.603
Peer-review started: March 28, 2021
First decision: October 4, 2021
Revised: October 23, 2021
Accepted: April 1, 2022
Article in press: April 1, 2022
Published online: April 19, 2022
Premenstrual syndrome (PMS) is the constellation of physical and psychological symptoms before menstruation. Premenstrual dysphoric disorder (PMDD) is a severe form of PMS with more depressive and anxiety symptoms. The Mini international neuropsychiatric interview, module U (MINI-U), assesses the diagnostic criteria for probable PMDD. The Premenstrual Symptoms screening tool (PSST) measures the severity of these symptoms.
To compare the PSST ordinal scores with the corresponding dichotomous MINI-U answers.
Arab women (n = 194) residing in Doha, Qatar, received the MINI-U and PSST. Receiver Operating Characteristics (ROC) analyses provided the cut-off scores on the PSST using MINI-U as a gold standard.
All PSST ratings were higher in participants with positive responses on MINI-U. In addition, ROC analyses showed that all areas under the curves were significant with the cutoff scores on PSST.
This study confirms that the severity measures from PSST can recognize patients with moderate/ severe PMS and PMDD who would benefit from immediate treatment.
Core Tip: This manuscript assesses the relationship between responses on the dichotomous the Mini international neuropsychiatric interview, module U (MINI-U) answers and the scores on the Premenstrual Symptoms screening tool (PSST). Our findings give reassurance that the MINI-U provides an adequate assessment for the probable diagnosis of Premenstrual dysphoric disorder (PMDD) and that the severity measures of the PSST can recognize patients with moderate/severe premenstrual syndrome and PMDD who would benefit from immediate treatment.